Vaxcyte Inc (PCVX) — Long-term Investment Intensity

Latest as of December 2025: 28.9%

Vaxcyte Inc (PCVX) has a Long-term Investment Intensity of 28.9% as of December 2025. Long-term investments of $881.66 Million represent 28.9% of total assets of $3.05 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Vaxcyte Inc (PCVX) net assets for net asset value and shareholders' equity analysis.

LT Investment Intensity

28.9%
LT Investments / Total Assets

Long-term Investments

$881.66 Million
USD

Total Assets

$3.05 Billion
USD

Country

USA
NASDAQ

Vaxcyte Inc Long-term Investment Intensity (2021–2025)

This chart shows how Vaxcyte Inc's Long-term Investment Intensity has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the intensity stands at 28.9%, reflecting long-term investments of $881.66 Million against total assets of $3.05 Billion USD. Also explore Vaxcyte Inc total assets for the complete picture of this company's asset base.

Annual Long-term Investment Intensity for Vaxcyte Inc (2021–2025)

The table below presents the year-by-year Long-term Investment Intensity for Vaxcyte Inc from 2021 to 2025, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market value of Vaxcyte Inc.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2025 28.9% $881.66 Million $3.05 Billion ▼ -10.6 pp
2024 39.5% $1.39 Billion $3.51 Billion ▲ +28.0 pp
2023 11.6% $162.68 Million $1.41 Billion ▲ +8.9 pp
2022 2.6% $26.55 Million $1.01 Billion ▼ -5.7 pp
2021 8.4% $27.12 Million $324.34 Million
pp = percentage points